Instadose Pharma Corp. (INSD)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Oct 5, 2026
Instadose Pharma Market Cap
Instadose Pharma has a market cap or net worth of $53.19 thousand as of October 9, 2026. It is the 51,287th most valuable company in the world and the 7,374th biggest in the United States. Its market cap has increased by 9,898.68% in one year.
Market Cap
53.19K
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#7,374 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since January 4, 2022, Instadose Pharma's market cap has decreased from 206.26M to 53.19K, a decrease of -99.97%. That is a compound annual growth rate of -82.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 5, 2026 | 53.19K | - |
| Dec 30, 2025 | 53.19K | -99.97% |
| Jan 4, 2022 | 206.26M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Endexx | 59.36K |
| Ayurcann Holdings | 58.41K |
| Hero Technologies | 56.37K |
| Nunzia Pharmaceutical Company | 43.45K |
| Emergent Health | 42.70K |
| BioTech Medics | 40.47K |
| Hemp, Inc | 40.02K |
| Onassis Holdings | 38.41K |